| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.7M | -30.4% |
| Cost of Revenue | $14.2M | -37.0% |
| Gross Profit | $5.5M | -4.7% |
| R&D Expense | $1.3M | -48.8% |
| SG&A Expense | $20.7M | -26.1% |
| Operating Income | -$15.2M | +31.6% |
| Pre-tax Income | -$21.7M | +14.7% |
| Net Income | $35.0M | +237.4% |
| EPS (Basic) | -$5.58 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $454K | -33.2% |
| Accounts Receivable | $1.3M | -17.9% |
| Inventory | $2.6M | -32.7% |
| Current Assets | $10.4M | -33.6% |
| Total Assets | $27.7M | -41.0% |
| Current Liabilities | $29.7M | +31.9% |
| Long-term Debt | $5.1M | -16.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.1M | +48.3% |
| Investing Cash Flow | $388K | +261.0% |
| Financing Cash Flow | $4.4M | -40.3% |
| +39.5% |
| EPS (Diluted) | -$5.58 | +39.5% |
| Total Liabilities |
| $36.8M |
| +3.3% |
| Stockholders' Equity | -$9.0M | -178.7% |